Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. The company is headquartered in Paddington, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company